Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Allez

Showing results (131-140 of 205) with videos related to

Pageof 21
Sort By:
Alimentary Pharmacology & Therapeutics|June 18, 2024
Systematic review: Patient-related, microbial, surgical, and histopathological risk factors for endoscopic post-operative recurrence in patients with Crohn's diseaseMichiel T J Bak, Karlijn Demers, Nassim Hammoudi, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspectsMatthieu Allez, Konstantinos Karmiris, Edouard Louis, et al.
Journal of Crohn'S & Colitis|September 20, 2022
Comparison of the Risk of Crohn's Disease Postoperative Recurrence Between Modified Rutgeerts Score i2a and i2b Categories: An Individual Patient Data Meta-analysisPauline Rivière, Joel Pekow, Nassim Hammoudi, et al.
Annals of the Rheumatic Diseases|June 25, 2018
Methotrexate and BAFF interaction prevents immunization against TNF inhibitorsSamuel Bitoun, Gaetane Nocturne, Bineta Ly, et al.
Microbiome|April 2, 2023
Diet prevents the expansion of segmented filamentous bacteria and ileo-colonic inflammation in a model of Crohn's diseaseAmira Metwaly, Jelena Jovic, Nadine Waldschmitt, et al.
Gut Microbes|May 31, 2022
Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancerAonghus Lavelle, Stéphane Nancey, Jean-Marie Reimund, et al.
Journal of Crohn'S & Colitis|December 7, 2018
Differences in Peripheral and Tissue Immune Cell Populations Following Haematopoietic Stem Cell Transplantation in Crohn's Disease PatientsAna M Corraliza, Elena Ricart, Alicia López-García, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 29, 2021
Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX TrialDavid Laharie, Geert D'Haens, Maria Nachury, et al.
Journal of Crohn'S & Colitis|February 10, 2022
Identification of Gene Expression Profiles Associated with an Increased Risk of Post-Operative Recurrence in Crohn's DiseaseMarjolaine Ngollo, Kevin Perez, Nassim Hammoudi, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2025
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort StudyNicolas Richard, Aurélien Amiot, Philippe Seksik, et al.
Pageof 21

Showing results (131-140 of 205) with videos related to

Sort By:
Pageof 21
Alimentary Pharmacology & Therapeutics|June 18, 2024
Systematic review: Patient-related, microbial, surgical, and histopathological risk factors for endoscopic post-operative recurrence in patients with Crohn's diseaseMichiel T J Bak, Karlijn Demers, Nassim Hammoudi, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspectsMatthieu Allez, Konstantinos Karmiris, Edouard Louis, et al.
Journal of Crohn'S & Colitis|September 20, 2022
Comparison of the Risk of Crohn's Disease Postoperative Recurrence Between Modified Rutgeerts Score i2a and i2b Categories: An Individual Patient Data Meta-analysisPauline Rivière, Joel Pekow, Nassim Hammoudi, et al.
Annals of the Rheumatic Diseases|June 25, 2018
Methotrexate and BAFF interaction prevents immunization against TNF inhibitorsSamuel Bitoun, Gaetane Nocturne, Bineta Ly, et al.
Microbiome|April 2, 2023
Diet prevents the expansion of segmented filamentous bacteria and ileo-colonic inflammation in a model of Crohn's diseaseAmira Metwaly, Jelena Jovic, Nadine Waldschmitt, et al.
Gut Microbes|May 31, 2022
Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancerAonghus Lavelle, Stéphane Nancey, Jean-Marie Reimund, et al.
Journal of Crohn'S & Colitis|December 7, 2018
Differences in Peripheral and Tissue Immune Cell Populations Following Haematopoietic Stem Cell Transplantation in Crohn's Disease PatientsAna M Corraliza, Elena Ricart, Alicia López-García, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 29, 2021
Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX TrialDavid Laharie, Geert D'Haens, Maria Nachury, et al.
Journal of Crohn'S & Colitis|February 10, 2022
Identification of Gene Expression Profiles Associated with an Increased Risk of Post-Operative Recurrence in Crohn's DiseaseMarjolaine Ngollo, Kevin Perez, Nassim Hammoudi, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2025
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort StudyNicolas Richard, Aurélien Amiot, Philippe Seksik, et al.
Pageof 21